MARKETS / NASDAQ / ALHC
NASDAQ · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP

Alignment Healthcare, Inc. ALHC

7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.9B
▲ 46.1% vs FY2024
EPS · FY25
$0.00
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-0.5%
Net margin · FY25
-0.0%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.9B
Revenue, FY2025 · full 7-year series below
Revenue Net income
12343.9-0.0201920222025
12343.9-0.0201920222025

The company lost 0 cents on every revenue dollar this year.

Per share
USD 0.00
Diluted EPS, FY2025
EPS
0.40.81.20.00201920222025
0.40.81.20.00201920222025

The company pays no cash dividend.

Profitability
-0.5%
Return on equity, FY2025
ROE
0.250.50.751-0.5%201920222025
0.250.50.751-0.5%201920222025
Operating margin0.4%
Net margin-0.0%
Return on assets-0.1%

Each USD of equity lost 1 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+32.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+40.2%
+32.8%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.20B
Shares outstanding, FY2025
0.160.20201920222025
0.160.20201920222025
Change, 5 years+24.4%
Change, 10 years

The share count grew 24% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.1B
total assets, end of FY2025
Total assetsUSD 1.1B
EquityUSD 179.3M
CashUSD 575.8M
Gross debtUSD 323.2M
Net debtUSD -252.6M
Current ratio1.71×

The company holds more cash than debt.

History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
3.9
2.7
1.8
1.4
1.2
1.0
0.8
Operating income $B
0.0
−0.1
−0.1
−0.1
−0.2
−0.0
−0.0
EBITDA $B
0.0
−0.1
−0.1
−0.1
−0.2
0.0
−0.0
Income tax $B
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.1
−0.1
−0.1
−0.2
−0.0
−0.0
EPS, diluted $
0.00
−0.67
−0.79
−0.83
−1.14
−0.15
−0.33
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
−0.5
−99.7
−74.9
−55.0
−116.0
−74.9
·
Shares out B
0.20
0.19
0.19
0.19
0.19
0.16
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
16 of 18
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 2 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed